Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) was the target of unusually large options trading activity on Friday. Stock traders bought 20,755 put options on the company. This is an increase of approximately 1,445% compared to the typical volume of 1,343 put options.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of SGRY. Point72 Asia Singapore Pte. Ltd. increased its position in Surgery Partners by 12.1% during the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock worth $91,000 after purchasing an additional 465 shares during the last quarter. PNC Financial Services Group Inc. grew its stake in shares of Surgery Partners by 86.4% in the 1st quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company's stock valued at $28,000 after buying an additional 542 shares during the period. AlphaQuest LLC increased its holdings in shares of Surgery Partners by 112.0% during the 1st quarter. AlphaQuest LLC now owns 1,058 shares of the company's stock worth $25,000 after buying an additional 559 shares during the last quarter. Mackenzie Financial Corp increased its holdings in shares of Surgery Partners by 2.8% during the 4th quarter. Mackenzie Financial Corp now owns 21,974 shares of the company's stock worth $465,000 after buying an additional 599 shares during the last quarter. Finally, Wells Fargo & Company MN raised its position in shares of Surgery Partners by 1.4% during the 4th quarter. Wells Fargo & Company MN now owns 56,931 shares of the company's stock valued at $1,205,000 after buying an additional 783 shares during the period.
Surgery Partners Price Performance
SGRY traded up $0.90 during trading on Monday, reaching $20.20. The company's stock had a trading volume of 2,322,108 shares, compared to its average volume of 1,178,439. The company has a quick ratio of 1.73, a current ratio of 1.89 and a debt-to-equity ratio of 1.09. The firm has a fifty day simple moving average of $22.36 and a two-hundred day simple moving average of $22.67. The company has a market cap of $2.59 billion, a price-to-earnings ratio of -13.20 and a beta of 1.93. Surgery Partners has a 1 year low of $18.87 and a 1 year high of $33.97.
Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). The company had revenue of $776.00 million for the quarter, compared to analysts' expectations of $777.77 million. Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 6.10%. The business's quarterly revenue was up 8.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.10 EPS. As a group, analysts anticipate that Surgery Partners will post 0.67 EPS for the current year.
Analyst Upgrades and Downgrades
SGRY has been the topic of a number of research reports. Benchmark reaffirmed a "buy" rating and issued a $35.00 price target on shares of Surgery Partners in a research note on Monday, April 21st. Macquarie reduced their target price on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a report on Tuesday, March 11th. Barclays decreased their target price on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 27th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and set a $35.00 price target on shares of Surgery Partners in a research report on Tuesday, March 25th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.56.
Get Our Latest Stock Report on Surgery Partners
Surgery Partners Company Profile
(
Get Free Report)
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Further Reading
Before you consider Surgery Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.
While Surgery Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.